Hereditary Spastic Paraplegia Type 50
2 clinical trials · Condition
◉ Watch Hereditary Spastic Paraplegia Type 50
| Record | Firm | Date |
|---|---|---|
| Phase 3 Efficacy Study With Concurrent Control of IT MELPIDA in SPG50.Concurrent Controls. (NCT06692712) | Elpida Therapeutics SPC | 2026-04-01 |
| Safety and Efficacy of AAV9/AP4B1 (BFB-101) For Patients With AP4B1-related Hereditary Spastic Paraplegia Type 47 (SPG47) (NCT06948019) | BlackfinBio Ltd | 2025-08-01 |
Track Hereditary Spastic Paraplegia Type 50 automatically
Every clearance here is in the API, with alerts when new ones post.